haematology
Blood cancers

Blood cancer patients at risk from CMV beyond HCT setting

Clinicians are advised to be vigilant following Australian research showing that cytomegalovirus (CMV) infection or disease is common in patients with haematological malignancies outside the haematopoietic cell transplant setting. A retrospective review of patients with haematological and solid organ cancers at the Peter MacCallum Cancer Centre between 2013 and 2020 found 25% of 953 patients ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic